Advertisement

Related Videos

Varsha Gandhi, PhD, on Ibrutinib

Deborah Collyar: What's In It for Patients?

Opening Session Panel Discussion

R. Donald Harvey, PharmD, BCOP, FCCP, FHOPA, on Alternative Dispensing Strategies

Mark J. Ratain, MD: The Justification for a Randomized Trial of Low-Dose Ibrutinib

Advertisement

Advertisement




Jan
07
Today In Oncology
Intravesical Cretostimogene Grenadenorepvec Shows Strong High-Grade Recurrence-Free Survival in BCG-Unresponsive Papillary-Only Non–Muscle-Invasive Bladder Cancer
IMvigor011 Subgroup Analysis: Role of ctDNA in Guiding Adjuvant Treatment for Muscle-Invasive Bladder Cancer
Study Finds Patients With Colon Cancer and Obesity Receiving GLP-1 RAs Had Significantly Reduced Risk of Mortality
A Novel Paradigm in Acute Kidney Injury Congestive Nephropathy in RCC With IVC Thrombus
Physical Activity and Fatigue QOL in Nonmetastatic CRC
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo